Potential of the conditionally replicative adenovirus Ad5-Delta24RGD in the treatment of malignant gliomas and its enhanced effect with radiotherapy.

Keywords

Oncolytic virus, Glioma, Cancer research, Retinoblastoma, Radiation therapy

References

• Characterization of integrin receptors in normal and neoplastic human brain.Werner Paulus, Inge Baur, Detlef Schuppan — 1993
• Viruses in the treatment of malignant gliomaMatthias Gromeier, Eckard Wimmer — 2001
• An adenovirus E1A mutant that demonstrates potent and selective systemic anti-tumoral efficacyCarla Heise, Terry Hermiston, Leisa Johnson — 2000
• Treatment of ovarian cancer with a tropism modified oncolytic adenovirus.Gerd Bauerschmitz, John Lam, Anna Kanerva — 2002
• Evaluation of genetically engineered herpes simplex viruses as oncolytic agents for human malignant brain tumors.Samita Andreansky, Liliana Soroceanu, Flotte Er — 1997
• A phase I trial of CV706, a replication-competent, PSA selective oncolytic adenovirus, for the treatment of locally recurrent prostate cancer following radiation therapy.Theodore L. DeWeese, H. Van der Poel, S. Li — 2001
• A controlled trial of intratumoral ONYX-015, a selectively-replicating adenovirus, in combination with cisplatin and 5-fluorouracil in patients with recurrent head and neck cancerFadlo R. Khuri, John Nemunaitis, Ian Ganly — 2000
• In vivo antitumor activity of ONYX-015 is influenced by p53 status and is augmented by radiotherapy.Kenneth Rogulski, Svend O. Freytag, Kang Zhang — 2000
• A monoclonal antibody specific for the cellular receptor for the group B coxsackievirusesKuo‐Hui Hsu, K. Lonberg-Holm, Barbara Alstein — 1988
• The organotypic multicellular spheroid is a relevant three-dimensional model to study adenovirus replication and penetration in human tumors in vitro.Jacques Grill, Martine L.M. Lamfers, Victor W. van Beusechem — 2002
• Strategies for enhancing viral-based gene therapy using ionizing radiation.Steven J. Chmura, Sunil J. Advani, D Kufe — 1999
• Detection of multiple gains and losses of genetic material in ten glioma cell lines by comparative genomic hybridizationGayatry Mohapatra, Dong Kim, Burt G. Feuerstein — 1995
• ONYX-015, an E1B gene-attenuated adenovirus, causes tumor-specific cytolysis and antitumoral efficacy that can be augmented by standard chemotherapeutic agentsCarla Heise, Adam Sampson-Johannes, Angelica Williams — 1997
• ONYX-015: mechanisms of action and clinical potential of a replication-selective adenovirusS. Ries, W. Michael Korn — 2002
• An Adenovirus Mutant That Replicates Selectively in p53- Deficient Human Tumor CellsJames R. Bischoff, David H. Kirn, Angelica Williams — 1996
• Multicellular tumor spheroids from human gliomas maintained in organ culture.Rolf Bjerkvig, Audun Tønnesen, Ole Didrik Lærum — 1990
• Enhancement of replication of genetically engineered herpes simplex viruses by ionizing radiation: a new paradigm for destruction of therapeutically intractable tumorsSJ Advani, GS Sibley, PY Song — 1998
• A Novel Three-Pronged Approach to Kill Cancer Cells Selectively: Concomitant Viral, Double Suicide Gene, and RadiotherapySvend O. Freytag, Kenneth Rogulski, Dell Paielli — 1998
• Dependence of efficient adenoviral gene delivery in malignant glioma cells on the expression levels of the Coxsackievirus and adenovirus receptor.Katsuyuki Asaoka, Mitsuhiro Tada, Yutaka Sawamura — 2000
• A conditionally replicative adenovirus with enhanced infectivity shows improved oncolytic potency.Kaori Suzuki, Juàn Fueyo, Victor Krasnykh — 2001

Cited by

• Oncolytic virotherapy for malignant glioma: translating laboratory insights into clinical practiceFerran Rius — 2013
• Selective Replicating Viral VectorsJohn Nemunaitis — 2012
• Adenovirus targeting for gene therapy of pancreatic cancerV. Geer, A. M., Link — 2011
• Gene therapy trials for the treatment of high-grade gliomas.Adam M Sonabend, Ilya V. Ulasov, Maciej S Lesniak — 2007
• Cancer Treatment with Gene Therapy and Radiation TherapySergey A. Kaliberov, Donald J. Buchsbaum — 2012
• Potentialisation de la virothérapie anti-tumorale basée sur des adénovirus oncolytiques dans le traitement des cancers côliques et rénauxChristian Bressy — 2013
• Gene therapy for gastric cancer: is it promising?Andreas Sutter, Henry Fechner — 2006
• Environmental risk assessment of replication competent viral vectors in gene therapy trialsAkker Hcm van den — 2008
• Bioprocess design of canine adenovirus vectors for gene therapy applicationsPaulo Fernandes — 2015
• Improving oncolytic adenoviral therapies for gastrointestinal cancers and tumor initiating cellsLotta Kangasniemi — 2010
• Molecular Determinants of Radiation ResponseTheodore L. DeWeese, Marikki Laiho — 2011
• Optimisation de la radiovirothérapie en associant un traitement radio-isotopique vectorisé par un virus de la rougeole oncolytique, une radiothérapie externe et une inhibition de checkpoint kinase-1Yann Touchefeu — 2013
• In vitro screening of clinical drugs identifies sensitizers of oncolytic viral therapy in glioblastoma stem-like cellsLotte M.E. Berghauser Pont, Rutger K. Balvers, Jenneke J. Kloezeman — 2015
• Adenoviral gene therapy for non-small cell lung cancerMerja Särkioja — 2008
• ONCOLYTIC ADENOVIRUSES FOR GYNECOLOGIC CANCERGerd Bauerschmitz — 2007
• Ras-dependent oncolysis with an adenovirus VAI mutant.Manel Cascalló, Gabriel Capellá, Adela Mazo — 2003
• Experimental adenovirus gene therapy for cancer patients with advanced tumors : Translational medicine from basic research to the patient's bedsidePetri Nokisalmi — 2013
• Adenoviral gene therapy for ovarian cancerAnna Kanerva — 2004
• Gene Therapy and Virotherapy: Novel Therapeutic Approaches for Brain TumorsKurt M. Kroeger, A.K.M. Ghulam Muhammad, Gregory J. Baker — 2010
• Oncolytic adenoviral therapy for glioblastoma multiforme.Adam M. Sonabend, Ilya V. Ulasov, Yu Han — 2006

Related papers

• Tissue inhibitor of metalloproteinase-3 expression from an oncolytic adenovirus inhibits matrix metalloproteinase activity in vivo without affecting antitumor efficacy in malignant glioma.Martine L.M. Lamfers, Davide Gianni, Ching‐Hsuan Tung — 2005
• The application of multiple miRNA response elements enables oncolytic adenoviruses to possess specificity to glioma cells.Weicheng Yao, Guocai Guo, Quanqin Zhang — 2014
• Treatment of malignant gliomas with stem cells mediated oncolytic adenovirusChunhua Yang — 2011
• Genetically modified adenoviruses against gliomasCandelaria Gomez‐Manzano, W. K. Alfred Yung, Ramón Alemany — 2004
• ICOVIR-5 shows E2F1 addiction and potent antiglioma effect in vivo.Marta M. Alonso, Manel Cascalló, Candelaria Gomez‐Manzano — 2007
• Oncolytic activity of the E1B-55 kDa-deleted adenovirus ONYX-015 is independent of cellular p53 status in human malignant glioma xenografts.Birgit Geoerger, Jacques Grill, Paule Opolon — 2002
• Application of mesenchymal stem cells as a vehicle to deliver replication-competent adenovirus for treating malignant gliomaHai Cui, Yongmin Jin, Wenbiao Jin — 2012
• Potent Antitumor Effect of Interleukin-24 Gene in the Survivin Promoter and Retinoblastoma Double-Regulated Oncolytic AdenovirusKang Jian Zhang, Yi Gang Wang, Xin Cao — 2009
• Preclinical characterization of the antiglioma activity of a tropism-enhanced adenovirus targeted to the retinoblastoma pathway.Juàn Fueyo, Ramón Alemany, Candelaria Gomez‐Manzano — 2003